New US Clinical Trial Seeks to Find New Treatment Option for TIPN

A new clinical trial, led by Columbia University in New York, USA, will look at the use of medical cannabis in breast cancer treatment. This first-of-its-kind trial could have an immense impact for the 67 per cent of women who deal with taxane-induced peripheral neuropathy (TIPN) during breast cancer treatment, through the use of medical cannabis.

 

View the full media release from Tilray, the medical cannabis provider: Media Release